세계의 백신 보관 장비 시장 : 제품별, 유형별, 최종사용자별, 지역별 - 예측(-2029년)

The global Vaccine storage equipment market is projected to reach USD 1.21 billion by 2029 from USD 0.86 billion in 2024, at a CAGR of 7.2% during the forecast period.

This is due to increasing need for temperature control to prevent vaccine loss and potential health hazard. Temperature control is critical in preventing vaccine wastage and ensuring the safety and efficacy of vaccines consequently increasing the demand for the vaccine storage equipment. However, the increased demand for the refurbished vaccine storage equipment in pharmaceutical industry and high energy cost and huge initial capital investment are the major restraint to the market. Additionally, the shortage of trained manpower & limited resourcces to maintain equipment is major challenge for the market growth. But, availability of cold chain logistics in developing countries and the increasing conditions necessitating vaccination is creating a conducive environment for market expansion over the forecast period of 2024-2029.

"The large capacity refrigerator segment of vaccine storage equipment market by type of refrigerator to hold largest position forecast period."

Based on the product, the vaccine storage equipment market is divided into refrigerators, freezers, vaccine carrier/cold box, monitoring devices and others. The market fro refrigerators is again divided into large capacity refrigerator and small capacity refrigerator. Among these, in 2023 large capacity refrigerator segment account for the largest market share in vaccine storage equipment market by refrigerator. These large capacity refrigerators are manufactured to hold large amounts of vaccine at precise temperatures, as these devices offer excellent temperature uniformity and plenty of storage space, large-capacity refrigerators are essential in healthcare facilities. The demand for these large capacity advanced refrigeration equipment is further increased by the rise in multi-dose vaccine production and the development of new vaccine types with particular storage needs. Consequently, the adoption of advanced large-capacity refrigerators to facilitate effective vaccine transportation and distribution is driving the expansion of large capacity refrigerator segment in vaccine storage equipment market.

"The vaccination center segment accounts for the second largest market share in vaccine storage equipment market."

Based on end user, the vaccine storage equipment market is segmented into vaccination centers, pharmaceutical centers, hospitals & clinics, and others including pharmacies, research laboratories, public health organizations. The vaccination centers segment accounts for the second largest market share in vaccine storage equipment market due to its pivotal role in storage of vaccines. In the supply chain for vaccines, vaccination centers are the last end users. Until the vaccines are administered to patients, these vaccination centers need to preserve the effectiveness and integrity of vaccines, thus vaccine storage equipment including refrigerator, freezer, vaccine carrier/cold boxes, monitoring devices are in huge demand in these centers. Additionally, vaccination facilities are the crucial nodes in the distribution network, owing to governments and international organizations making significant investments in immunization programs. This directly affects the need for state-of-the-art vaccine storage equipment.

"Europe accounted for the second largest share of the vaccine storage equipment market by region."

The global vaccine storage equipment market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa and GCC Countries. Europe is the second largest regional market for vaccine storage equipment equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Europe holds the second-largest position in the vaccine storage equipment market. This is due to the presence of key industry players such as Eppendorf SE (Germany), Dulas Ltd. (UK), Arctiko Ltd (UK), Philipp Kirsch GmbH, A Hettich Group Company (Germany), and Labcold Limited (UK). These major European players are making significant investments in R&D to create cutting-edge, innovative equipment. Furthermore, the European region's strong pharmaceutical manufacturing base, established regulatory framework, and focus on technological advancements all contribute to its strong market position. In Europe, the need for vaccine storage equipment is being driven by innovation and industry leadership.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
• By Designation: C-level-50%, Director-level-30% and Others-20%
• By Region: North America-38%, Europe-26%, Asia Pacific-15%, Latin America- 11%, and Middle east and Africa-7% and GCC countries-3%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the vaccine storage equipment market market are Cardinal Health Inc. (US), Eppendorf SE (Germany), Thermo Fisher Scientific Inc. (US), PHC Holdings Corporation (Japan), Standex International Corporation (US), Blue Star Limited (India), Azenta Inc. (US), Haier biomedical (China), Dulas Ltd. (UK), MVE Biological Solutions (US), Arctiko Ltd (UK), EVERMED S.r.l., A Everlasting group Company (Italy), Philipp Kirsch GmbH, A Hettich Group Company (Germany), and Labcold Limited (UK)

Research Coverage

This report studies the vaccine storage equipment market based on product, type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers (Need For Temperature control to prevent vaccine loss and potential health hazard, Increasing government & various regulatory body support for the establishment and maintenance of an efficient vaccine cold chain system), restraints (High energy cost and need for capital investments) , Challenge (Shortage of trained manpower & limited resources to maintain equipment, Environmental concerns regarding greenhouse gas emissions), opportunity (Availability of cold chain logistics in developing countries, The escalation in conditions necessitating vaccination creates a conducive environment for market expansion)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pain management devices market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the vaccine storage equipment market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET RANKING ANALYSIS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 VACCINE STORAGE EQUIPMENT MARKET OVERVIEW
• 4.2 EUROPE: VACCINE STORAGE EQUIPMENT MARKET, BY PRODUCT
• 4.3 VACCINE STORAGE EQUIPMENT MARKET: GEOGRAPHIC SNAPSHOT
• 4.4 GEOGRAPHIC MIX: VACCINE STORAGE EQUIPMENT MARKET, 2024-2029 (USD MILLION)
• 4.5 VACCINE STORAGE EQUIPMENT MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES, 2024 VS. 2029 (USD MILLION)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Need for temperature control to prevent vaccine loss and potential health hazards
    • 5.2.1.2 Increasing government & regulatory body support for establishing and maintaining vaccine cold chain systems
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High energy costs and need for capital investments
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising disease prevalence to boost demand for vaccination and storage equipment
    • 5.2.3.2 Availability of cold chain logistics in developing countries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of trained manpower & limited resources to maintain equipment
    • 5.2.4.2 Environmental concerns regarding greenhouse gas emissions
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Thermoelectric cooling
    • 5.3.1.2 Solar direct drive
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Temperature control and tracking systems
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 Thermal insulation
• 5.4 INDUSTRY TRENDS
  • 5.4.1 GROWTH OF IOT-ENABLED SOLUTIONS IN VACCINE STORAGE EQUIPMENT FOR ENHANCED MONITORING AND EFFICIENCY
  • 5.4.2 RISING EMPHASIS ON ENERGY EFFICIENCY
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 SUPPLY CHAIN ANALYSIS
• 5.8 TRADE ANALYSIS
  • 5.8.1 IMPORT SCENARIO FOR HS CODE 8418
  • 5.8.2 EXPORT SCENARIO FOR HS CODE 8418
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF BUYERS
  • 5.9.4 BARGAINING POWER OF SUPPLIERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.10.2 BUYING CRITERIA
• 5.11 REGULATORY LANDSCAPE
  • 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11.2 REGULATORY ANALYSIS
    • 5.11.2.1 NORTH AMERICA
      • 5.11.2.1.1 US
      • 5.11.2.1.2 Canada
    • 5.11.2.2 Europe
    • 5.11.2.3 Asia Pacific
    • 5.11.2.4 Latin America
    • 5.11.2.5 Middle East & Africa and GCC Countries
• 5.12 PATENT ANALYSIS
  • 5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.13 PRICING ANALYSIS
  • 5.13.1 INDICATIVE PRICE TREND OF VACCINE STORAGE EQUIPMENT, BY KEY PLAYER
  • 5.13.2 INDICATIVE PRICE TREND OF VACCINE STORAGE EQUIPMENT, BY REGION
• 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.15 ADJACENT MARKET ANALYSIS
  • 5.15.1 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION MARKET
• 5.16 UNMET NEEDS/END-USER EXPECTATIONS
• 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.18 INVESTMENT & FUNDING SCENARIO
• 5.19 IMPACT OF AI ON VACCINE STORAGE EQUIPMENT MARKET

6 VACCINE STORAGE EQUIPMENT MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 REFRIGERATORS
  • 6.2.1 LARGE-CAPACITY REFRIGERATORS
    • 6.2.1.1 Growing immunization programs to drive demand for refrigerators
  • 6.2.2 SMALL-CAPACITY REFRIGERATORS
    • 6.2.2.1 Adoption of advanced technologies by key players to drive market
• 6.3 FREEZERS
  • 6.3.1 LOW-TEMPERATURE FREEZERS
    • 6.3.1.1 Rising demand from small-scale laboratories and pharmacies to boost growth
  • 6.3.2 ULTRA-LOW-TEMPERATURE FREEZERS
    • 6.3.2.1 High vaccine storage capacity to drive adoption
• 6.4 VACCINE CARRIERS/COLD BOXES
  • 6.4.1 STANDARD VACCINE CARRIERS/COLD BOXES
    • 6.4.1.1 Initiatives led by several agencies to boost market growth
  • 6.4.2 FREEZE-PREVENTIVE VACCINE CARRIERS/COLD BOXES
    • 6.4.2.1 Rising demand for temperature-sensitive vaccines to aid market growth
• 6.5 MONITORING DEVICES
  • 6.5.1 TEMPERATURE MONITORING SYSTEMS
    • 6.5.1.1 Adoption of innovative technologies in temperature monitoring devices to drive market
  • 6.5.2 ALARM & ALERT SYSTEMS
    • 6.5.2.1 Regulatory compliance, automation, and smart storage solutions to drive market
• 6.6 OTHER PRODUCTS

7 VACCINE STORAGE EQUIPMENT MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 REFRIGERATED STORAGE
  • 7.2.1 STRICT REGULATORY COMPLIANCE AND GOVERNMENT SUPPORT TO BOOST MARKET
• 7.3 REFRIGERATED TRANSPORT
  • 7.3.1 FOCUS ON ENHANCING COLD CHAIN INFRASTRUCTURE WITH SUSTAINABLE SOLUTIONS TO AID MARKET GROWTH

8 VACCINE STORAGE EQUIPMENT MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS & CLINICS
  • 8.2.1 RISING FUNDING PROGRAMS TO BUILD INFRASTRUCTURE TO AID MARKET GROWTH
• 8.3 VACCINATION CENTERS
  • 8.3.1 INCREASING IMMUNIZATION PROGRAMS CONDUCTED TO DRIVE MARKET
• 8.4 PHARMACEUTICAL COMPANIES
  • 8.4.1 COLLABORATIVE INITIATIVES BY PHARMACEUTICAL COMPANIES FOR VACCINE DEVELOPMENT TO BOOST MARKET GROWTH
• 8.5 OTHER END USERS

9 VACCINE STORAGE EQUIPMENT MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominates North American vaccine storage equipment market
  • 9.2.3 CANADA
    • 9.2.3.1 Stringent regulatory guidelines for vaccine storage and handling to propel market growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany accounted for largest share of European market in 2023
  • 9.3.3 FRANCE
    • 9.3.3.1 Increasing investments by biopharma companies to drive market
  • 9.3.4 ITALY
    • 9.3.4.1 Rising vaccine manufacturing and local innovation to drive market
  • 9.3.5 UK
    • 9.3.5.1 Expanding vaccination coverage to propel demand for storage equipment
  • 9.3.6 SPAIN
    • 9.3.6.1 Increasing incidence of infectious diseases in Spain to drive market
  • 9.3.7 NORDIC COUNTRIES
    • 9.3.7.1 Increasing investment by manufacturers to drive market
  • 9.3.8 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Japan to hold largest market share in APAC
  • 9.4.3 CHINA
    • 9.4.3.1 Stringent regulations and enhanced immunization guidelines to drive market
  • 9.4.4 INDIA
    • 9.4.4.1 Rising awareness campaigns to propel market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Government initiatives and awareness campaigns to propel market growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Increasing geriatric population to drive market growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Rising disease prevalence and mRNA research to boost demand for vaccine storage equipment in Brazil
  • 9.5.3 MEXICO
    • 9.5.3.1 Emphasis on vaccination campaigns to drive demand for storage equipment
  • 9.5.4 ARGENTINA
    • 9.5.4.1 Rising infectious disease prevalence and vaccine production to support adoption
  • 9.5.5 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 EXPANSION OF VACCINE PRODUCTION TO SUPPORT MARKET GROWTH
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST AND AFRICA
• 9.7 GCC COUNTRIES
  • 9.7.1 STRATEGIC INVESTMENTS BY PHARMACEUTICAL COMPANIES TO BOOST MARKET GROWTH
  • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VACCINE STORAGE EQUIPMENT MARKET
• 10.3 REVENUE ANALYSIS, 2021-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Product footprint
    • 10.5.5.4 Type footprint
    • 10.5.5.5 End-user footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 VALUATION & FINANCIAL METRICS
  • 10.7.1 FINANCIAL METRICS
  • 10.7.2 COMPANY VALUATION
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS
  • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 THERMO FISHER SCIENTIFIC INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 CARDINAL HEALTH, INC.
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 MnM view
      • 11.1.2.3.1 Key strengths
      • 11.1.2.3.2 Strategic choices
      • 11.1.2.3.3 Weaknesses & competitive threats
  • 11.1.3 EPPENDORF SE
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 MnM view
      • 11.1.3.3.1 Key strengths
      • 11.1.3.3.2 Strategic choices
      • 11.1.3.3.3 Weaknesses & competitive threats
  • 11.1.4 AZENTA, INC.
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Deals
      • 11.1.4.3.2 Other developments
  • 11.1.5 PHC HOLDINGS CORPORATION
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Expansions
  • 11.1.6 STANDEX INTERNATIONAL CORPORATION
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
  • 11.1.7 BLUE STAR LIMITED
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Expansions
  • 11.1.8 HAIER BIOMEDICAL
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product approvals
  • 11.1.9 DULAS LTD.
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 MVE BIOLOGICAL SOLUTIONS
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
  • 11.1.11 ARCTIKO LTD.
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
  • 11.1.12 EVERMED S.R.L. (EVERLASTING GROUP)
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 PHILIPP KIRSCH GMBH (HETTICH GROUP)
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 LABCOLD LIMITED
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 HELMER SCIENTIFIC INC. (TRANE TECHNOLOGIES)
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 THERMOLINE SCIENTIFIC
  • 11.2.2 DICKSON DATA
  • 11.2.3 SO-LOW ENVIRONMENTAL EQUIPMENT CO.
  • 11.2.4 VESTFROST SOLUTIONS
  • 11.2.5 ZHONGKE MEILING CRYOGENICS COMPANY LIMITED
  • 11.2.6 APOTHECARIES SUNDRIES MFG. PRIVATE LIMITED
  • 11.2.7 HELAPET (CLINIMED)
  • 11.2.8 NUAIRE, INC.
  • 11.2.9 NIHON FREEZER CO., LTD
  • 11.2.10 ROCKWELL INDUSTRIES LIMITED

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS